| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |